Patients with lung cancer undergoing immune checkpoint inhibitors: A meta-analysis of dermatological toxicities
Náthali Felícia Mineiro dos Santos Garrett, Ana Cristina Carvalho da Costa, Giovanni Damiani, Christiane Inocêncio Vasques
Topics & Concepts
MedicineNivolumabAtezolizumabPembrolizumabIpilimumabRashLung cancerAdverse effectOncologyDermatologyInternal medicineAvelumabSkin cancerPneumonitisCancerImmunotherapyLungCancer Immunotherapy and BiomarkersCancer Diagnosis and TreatmentColorectal Cancer Treatments and Studies